2 - {-3-`2-(phenyl)-oxazol-4-ylmethoxymeth yl!-cyclohexylmethoxy}-propionic acid derivatives used as PPAR ligandes (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes

Details for Australian Patent Application No. 2005274495 (hide)

International Classifications

Event Publications

8 March 2007 PCT application entered the National Phase

PCT publication WO2006/018118 Priority application(s): WO2006/018118

23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.